US5536475A
(en)
*
|
1988-10-11 |
1996-07-16 |
Baxter International Inc. |
Apparatus for magnetic cell separation
|
WO1994011078A1
(en)
*
|
1992-11-16 |
1994-05-26 |
Immunivest Corporation |
Magnetic immobilization and manipulation of biological entities
|
US5200084A
(en)
*
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
US6013532A
(en)
*
|
1990-09-26 |
2000-01-11 |
Immunivest Corporation |
Methods for magnetic immobilization and manipulation of cells
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US5622831A
(en)
*
|
1990-09-26 |
1997-04-22 |
Immunivest Corporation |
Methods and devices for manipulation of magnetically collected material
|
US5646001A
(en)
*
|
1991-03-25 |
1997-07-08 |
Immunivest Corporation |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5466574A
(en)
*
|
1991-03-25 |
1995-11-14 |
Immunivest Corporation |
Apparatus and methods for magnetic separation featuring external magnetic means
|
WO1994007138A1
(en)
|
1992-09-14 |
1994-03-31 |
Fodstad Oystein |
Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
|
FI930440A0
(fi)
|
1993-02-01 |
1993-02-01 |
Labsystems Oy |
Bestaemningsfoerfarande
|
EP1130397B1
(de)
*
|
1993-02-01 |
2006-10-11 |
Thermo Electron Oy |
Gerät zur Bestimmung eines Analyten in einer Probe
|
FI932866A0
(fi)
*
|
1993-06-21 |
1993-06-21 |
Labsystems Oy |
Separeringsfoerfarande
|
NO180658C
(no)
*
|
1994-03-10 |
1997-05-21 |
Oeystein Fodstad |
Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
|
JP3115501B2
(ja)
*
|
1994-06-15 |
2000-12-11 |
プレシジョン・システム・サイエンス株式会社 |
分注機を利用した磁性体の脱着制御方法及びこの方法によって処理される各種装置
|
DE4421058A1
(de)
|
1994-06-16 |
1995-12-21 |
Boehringer Mannheim Gmbh |
Verfahren zur magnetischen Abtrennung von Flüssigkeitskomponenten
|
DE4423878A1
(de)
*
|
1994-07-07 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Vorrichtung und Verfahren zum Abscheiden von magnetischen Mikropartikeln
|
WO1996004558A1
(fr)
*
|
1994-07-29 |
1996-02-15 |
Iatron Laboratories, Inc. |
Systeme de mesure fonctionnant avec du sang entier
|
US5871625A
(en)
*
|
1994-08-25 |
1999-02-16 |
University Of Iowa Research Foundation |
Magnetic composites for improved electrolysis
|
NO180167C
(no)
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
US5567326A
(en)
*
|
1994-09-19 |
1996-10-22 |
Promega Corporation |
Multisample magnetic separation device
|
US5693784A
(en)
*
|
1994-09-19 |
1997-12-02 |
Promega Corporation |
Methods for creating agglomerates from colloidal particles
|
US5646263A
(en)
*
|
1994-09-19 |
1997-07-08 |
Promega Corporation |
High efficiency method for isolating target substances using a multisample separation device
|
FI944940A0
(fi)
*
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Tvaofasigt separeringsfoerfarande
|
FI944938A0
(fi)
*
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Foerflyttningsanordning
|
FI944939A0
(fi)
*
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Foerfarande foer separering av partiklar
|
FI944937A0
(fi)
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Separeringsanordning
|
US5750339A
(en)
*
|
1994-11-30 |
1998-05-12 |
Thomas Jefferson University |
Methods for identifying fetal cells
|
US5628407A
(en)
*
|
1994-12-05 |
1997-05-13 |
Bolt Beranek And Newman, Inc. |
Method and apparatus for separation of magnetically responsive spheres
|
US5705059A
(en)
*
|
1995-02-27 |
1998-01-06 |
Miltenyi; Stefan |
Magnetic separation apparatus
|
JP3630493B2
(ja)
*
|
1995-03-20 |
2005-03-16 |
プレシジョン・システム・サイエンス株式会社 |
分注機を利用した液体処理方法およびその装置
|
US5741714A
(en)
*
|
1995-07-18 |
1998-04-21 |
Immunivest Corporation |
Detection of bound analyte by magnetic partitioning and masking
|
US5660990A
(en)
*
|
1995-08-18 |
1997-08-26 |
Immunivest Corporation |
Surface immobilization of magnetically collected materials
|
NO961031D0
(no)
|
1996-03-13 |
1996-03-13 |
Det Norske Radiumshospital Tum |
Fremgangsmåte til å drepe uönskede målceller
|
US5888835A
(en)
*
|
1996-05-10 |
1999-03-30 |
Chiron Diagnostics Corporation |
Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
|
US6143578A
(en)
*
|
1996-05-10 |
2000-11-07 |
Bayer Corporation |
Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
|
US6790366B2
(en)
*
|
1996-06-07 |
2004-09-14 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US6890426B2
(en)
*
|
1996-06-07 |
2005-05-10 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
EP0920627B1
(de)
*
|
1996-06-07 |
2004-05-12 |
Immunivest Corporation |
Magnetische trennung mit hilfe von externen und internen gradienten
|
US7666308B2
(en)
*
|
1996-06-07 |
2010-02-23 |
Veridex, Llc. |
Magnetic separation apparatus and methods
|
US6136182A
(en)
*
|
1996-06-07 |
2000-10-24 |
Immunivest Corporation |
Magnetic devices and sample chambers for examination and manipulation of cells
|
US6660159B1
(en)
|
1996-06-07 |
2003-12-09 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US5856194A
(en)
|
1996-09-19 |
1999-01-05 |
Abbott Laboratories |
Method for determination of item of interest in a sample
|
US5795784A
(en)
|
1996-09-19 |
1998-08-18 |
Abbott Laboratories |
Method of performing a process for determining an item of interest in a sample
|
US6623983B1
(en)
*
|
1997-03-25 |
2003-09-23 |
Immunivest Corporation |
Apparatus and methods for capture and analysis of particulate entities
|
DE69834527T2
(de)
*
|
1997-07-01 |
2007-05-10 |
VLP Watertown Limited Partnership, Watertown |
Verfahren zur Geschlechtsbestimmung von Säuger-Nachkommenschaft
|
AU760560B2
(en)
|
1998-02-12 |
2003-05-15 |
Board Of Regents, The University Of Texas System |
Methods and reagents for the rapid and efficient isolation of circulating cancer cells
|
DE69934449T2
(de)
*
|
1998-03-12 |
2007-09-27 |
Miltenyi Biotech Gmbh |
Mikrokolonnen-System für Magnettrennung
|
US6361749B1
(en)
*
|
1998-08-18 |
2002-03-26 |
Immunivest Corporation |
Apparatus and methods for magnetic separation
|
US6150182A
(en)
*
|
1998-11-30 |
2000-11-21 |
Cassaday; Michael M. |
Method for separation of components in a biochemical reaction utilizing a combination of magnetic and centrifugal processes
|
US7364921B1
(en)
|
1999-01-06 |
2008-04-29 |
University Of Medicine And Dentistry Of New Jersey |
Method and apparatus for separating biological materials and other substances
|
WO2000040947A1
(en)
*
|
1999-01-06 |
2000-07-13 |
University Of Medicine And Dentistry Of New Jersey |
Method and apparatus for separating biological materials and other substances
|
US6159378A
(en)
*
|
1999-02-23 |
2000-12-12 |
Battelle Memorial Institute |
Apparatus and method for handling magnetic particles in a fluid
|
WO2000062034A2
(en)
*
|
1999-04-09 |
2000-10-19 |
Shot, Inc. |
Multistage electromagnetic separator for purifying cells, chemicals and protein structures
|
US20040058401A1
(en)
*
|
1999-04-13 |
2004-03-25 |
Blaise Bossy |
Method for detecting rare event
|
US6623982B1
(en)
*
|
1999-07-12 |
2003-09-23 |
Immunivest Corporation |
Increased separation efficiency via controlled aggregation of magnetic nanoparticles
|
DE19938372A1
(de)
*
|
1999-08-09 |
2001-03-08 |
Diagnostikforschung Inst |
Verfahren und Vorrichtung zur Trennung magnetischer Teilchen
|
AU778569B2
(en)
|
1999-09-03 |
2004-12-09 |
Miltenyi Biotec Gmbh |
Methods of modification of selected cells in a magnetic cell separation column
|
US20040009486A1
(en)
*
|
1999-10-29 |
2004-01-15 |
Sorge Joseph A. |
Compositions and methods utilizing DNA polymerases
|
CA2397341A1
(en)
*
|
2000-01-13 |
2001-07-19 |
Dhanesh Gohel |
Ferrofluid based arrays
|
US6672458B2
(en)
*
|
2000-05-19 |
2004-01-06 |
Becton, Dickinson And Company |
System and method for manipulating magnetically responsive particles fluid samples to collect DNA or RNA from a sample
|
DK1311820T3
(en)
*
|
2000-07-14 |
2015-04-07 |
Janssen Diagnostics Llc |
Increased separation efficiency via a controlled aggregation of magnetic nanoparticles
|
US20020100582A1
(en)
*
|
2000-09-05 |
2002-08-01 |
Oldenburg Kevin R. |
Rapid thermal cycling device
|
BR0107168A
(pt)
*
|
2000-09-05 |
2002-06-18 |
Kawasaki Steel Co |
Aparelho de filtro magnético
|
CN1231758C
(zh)
*
|
2000-10-19 |
2005-12-14 |
泰博特克公司 |
操作用于识别目的的微载体的方法
|
DE10057396C1
(de)
|
2000-11-18 |
2002-04-04 |
Karlsruhe Forschzent |
Verfahren zum Abtrennen eines dispergierten oder gelösten Stoffes und Magnetseparator
|
US20020164659A1
(en)
*
|
2000-11-30 |
2002-11-07 |
Rao Galla Chandra |
Analytical methods and compositions
|
KR20030066766A
(ko)
*
|
2001-01-05 |
2003-08-09 |
이뮤니베스트 코포레이션 |
피사체를 이미지화하는 장치 및 방법
|
US20020166760A1
(en)
*
|
2001-05-11 |
2002-11-14 |
Prentiss Mara G. |
Micromagentic systems and methods for microfluidics
|
WO2002093140A1
(en)
*
|
2001-05-14 |
2002-11-21 |
Johns Hopkins University |
Multifunctional magnetic nanowires
|
DE10127069A1
(de)
*
|
2001-05-23 |
2002-11-28 |
Bio Medical Apherese Systeme G |
Magnetfilter zur Abtrennung von strömenden magnetischen Objekten
|
US7169577B2
(en)
*
|
2001-07-27 |
2007-01-30 |
Surface Logix, Inc. |
Cell isolation and screening device and method of using same
|
US7169578B2
(en)
*
|
2001-07-27 |
2007-01-30 |
Surface Logix, Inc. |
Cell isolation and screening device and method of using same
|
US7285412B2
(en)
*
|
2001-07-27 |
2007-10-23 |
Surface Logix Inc. |
Device for magnetic immobilization of cells
|
US7863012B2
(en)
*
|
2004-02-17 |
2011-01-04 |
Veridex, Llc |
Analysis of circulating tumor cells, fragments, and debris
|
US20030095897A1
(en)
*
|
2001-08-31 |
2003-05-22 |
Grate Jay W. |
Flow-controlled magnetic particle manipulation
|
US8980568B2
(en)
|
2001-10-11 |
2015-03-17 |
Aviva Biosciences Corporation |
Methods and compositions for detecting non-hematopoietic cells from a blood sample
|
US8986944B2
(en)
|
2001-10-11 |
2015-03-24 |
Aviva Biosciences Corporation |
Methods and compositions for separating rare cells from fluid samples
|
CA2469464A1
(en)
*
|
2001-12-07 |
2003-06-19 |
Dyax Corporation |
Method and apparatus for washing magnetically responsive particles
|
US7098041B2
(en)
|
2001-12-11 |
2006-08-29 |
Kimberly-Clark Worldwide, Inc. |
Methods to view and analyze the results from diffraction-based diagnostics
|
US7102752B2
(en)
*
|
2001-12-11 |
2006-09-05 |
Kimberly-Clark Worldwide, Inc. |
Systems to view and analyze the results from diffraction-based diagnostics
|
US20030119057A1
(en)
*
|
2001-12-20 |
2003-06-26 |
Board Of Regents |
Forming and modifying dielectrically-engineered microparticles
|
US8367013B2
(en)
*
|
2001-12-24 |
2013-02-05 |
Kimberly-Clark Worldwide, Inc. |
Reading device, method, and system for conducting lateral flow assays
|
US20030119203A1
(en)
*
|
2001-12-24 |
2003-06-26 |
Kimberly-Clark Worldwide, Inc. |
Lateral flow assay devices and methods for conducting assays
|
US7373968B2
(en)
*
|
2002-01-08 |
2008-05-20 |
Kevin R. Oldenburg |
Method and apparatus for manipulating an organic liquid sample
|
JP2005522679A
(ja)
*
|
2002-04-12 |
2005-07-28 |
インストゥルメンテイション ラボラトリー カンパニー |
イムノアッセイプローブ
|
US7998923B2
(en)
*
|
2002-05-07 |
2011-08-16 |
The Regents Of The University Of California |
Bioactivation of particles
|
GB0215185D0
(en)
*
|
2002-07-01 |
2002-08-07 |
Genovision As |
Binding a target substance
|
US7285424B2
(en)
*
|
2002-08-27 |
2007-10-23 |
Kimberly-Clark Worldwide, Inc. |
Membrane-based assay devices
|
US7432105B2
(en)
*
|
2002-08-27 |
2008-10-07 |
Kimberly-Clark Worldwide, Inc. |
Self-calibration system for a magnetic binding assay
|
US7314763B2
(en)
*
|
2002-08-27 |
2008-01-01 |
Kimberly-Clark Worldwide, Inc. |
Fluidics-based assay devices
|
US7781172B2
(en)
*
|
2003-11-21 |
2010-08-24 |
Kimberly-Clark Worldwide, Inc. |
Method for extending the dynamic detection range of assay devices
|
US20040106190A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Kimberly-Clark Worldwide, Inc. |
Flow-through assay devices
|
US7247500B2
(en)
*
|
2002-12-19 |
2007-07-24 |
Kimberly-Clark Worldwide, Inc. |
Reduction of the hook effect in membrane-based assay devices
|
US20040142384A1
(en)
*
|
2003-01-16 |
2004-07-22 |
Cohen Barb Ariel |
Magnetic separator
|
US20040157219A1
(en)
*
|
2003-02-06 |
2004-08-12 |
Jianrong Lou |
Chemical treatment of biological samples for nucleic acid extraction and kits therefor
|
US20040197819A1
(en)
*
|
2003-04-03 |
2004-10-07 |
Kimberly-Clark Worldwide, Inc. |
Assay devices that utilize hollow particles
|
US7851209B2
(en)
*
|
2003-04-03 |
2010-12-14 |
Kimberly-Clark Worldwide, Inc. |
Reduction of the hook effect in assay devices
|
US7282180B2
(en)
*
|
2003-07-02 |
2007-10-16 |
Immunivest Corporation |
Devices and methods to image objects
|
US7527741B2
(en)
*
|
2003-07-24 |
2009-05-05 |
Ryoichi Aogaki |
Microreactor including magnetic barrier
|
US7956175B2
(en)
|
2003-09-11 |
2011-06-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of bacteria
|
AU2003285133A1
(en)
*
|
2003-11-05 |
2005-06-24 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Biofunctionalized quantum dots for biological imaging
|
US7713748B2
(en)
*
|
2003-11-21 |
2010-05-11 |
Kimberly-Clark Worldwide, Inc. |
Method of reducing the sensitivity of assay devices
|
US7943395B2
(en)
*
|
2003-11-21 |
2011-05-17 |
Kimberly-Clark Worldwide, Inc. |
Extension of the dynamic detection range of assay devices
|
US20050112703A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Kimberly-Clark Worldwide, Inc. |
Membrane-based lateral flow assay devices that utilize phosphorescent detection
|
US7943089B2
(en)
*
|
2003-12-19 |
2011-05-17 |
Kimberly-Clark Worldwide, Inc. |
Laminated assay devices
|
US20050136550A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Kimberly-Clark Worldwide, Inc. |
Flow control of electrochemical-based assay devices
|
AU2004237844B2
(en)
|
2003-12-23 |
2011-01-27 |
Therakos, Inc. |
Extracorporeal photopheresis in combination with anti-TNF treatment
|
WO2005065267A2
(en)
*
|
2003-12-24 |
2005-07-21 |
Massachusetts Institute Of Technology |
Magnetophoretic cell clarification
|
WO2005072855A1
(en)
|
2004-01-28 |
2005-08-11 |
Drexel University |
Magnetic fluid manipulators and methods for their use
|
US20070281323A1
(en)
|
2004-02-03 |
2007-12-06 |
Wolfert Robert L |
Methods Of Detecting Lp-PLA2 Activity
|
US7255787B2
(en)
*
|
2004-02-14 |
2007-08-14 |
Aaron Bush |
Device and method for increasing viability in cell types
|
US20050181353A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Rao Galla C. |
Stabilization of cells and biological specimens for analysis
|
US20050239091A1
(en)
*
|
2004-04-23 |
2005-10-27 |
Collis Matthew P |
Extraction of nucleic acids using small diameter magnetically-responsive particles
|
US8211386B2
(en)
*
|
2004-06-08 |
2012-07-03 |
Biokit, S.A. |
Tapered cuvette and method of collecting magnetic particles
|
WO2006093516A2
(en)
|
2004-06-22 |
2006-09-08 |
The Regents Of The University Of California |
Peptide-coated nanoparticles with graded shell compositions
|
US7906276B2
(en)
|
2004-06-30 |
2011-03-15 |
Kimberly-Clark Worldwide, Inc. |
Enzymatic detection techniques
|
US7094528B2
(en)
*
|
2004-06-30 |
2006-08-22 |
Kimberly-Clark Worldwide, Inc. |
Magnetic enzyme detection techniques
|
US7521226B2
(en)
*
|
2004-06-30 |
2009-04-21 |
Kimberly-Clark Worldwide, Inc. |
One-step enzymatic and amine detection technique
|
US20060024204A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Oldenburg Kevin R |
Well plate sealing apparatus and method
|
US20060024776A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Mcmillian Ray |
Magnetic particle capture of whole intact organisms from clinical samples
|
AU2005271688B2
(en)
*
|
2004-08-03 |
2011-10-06 |
Becton, Dickinson And Company |
Use of magnetic material to direct isolation of compounds and fractionation of multipart samples
|
AU2005271687A1
(en)
*
|
2004-08-03 |
2006-02-16 |
Becton, Dickinson And Company |
Use of magnetic material to fractionate samples
|
JP2006281133A
(ja)
*
|
2005-04-01 |
2006-10-19 |
Tokyo Institute Of Technology |
磁気ビーズセパレータ
|
US7749445B2
(en)
*
|
2005-05-02 |
2010-07-06 |
Bioscale, Inc. |
Method and apparatus for analyzing bioprocess fluids
|
US7611908B2
(en)
*
|
2005-05-02 |
2009-11-03 |
Bioscale, Inc. |
Method and apparatus for therapeutic drug monitoring using an acoustic device
|
US7648844B2
(en)
*
|
2005-05-02 |
2010-01-19 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using an acoustic device
|
US7300631B2
(en)
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
US7901950B2
(en)
*
|
2005-08-12 |
2011-03-08 |
Veridex, Llc |
Method for assessing disease states by profile analysis of isolated circulating endothelial cells
|
EP2443922B1
(de)
|
2005-11-02 |
2017-05-03 |
Therakos, Inc. |
Ex-vivo-Verwendung apoptotischer Zellen zur Erzeugung regulatorischer T-Zellen
|
JP2009537021A
(ja)
*
|
2006-05-12 |
2009-10-22 |
ベリデックス・リミテッド・ライアビリティ・カンパニー |
蛍光顕微鏡法におけるレーザー照射システム
|
AU2007255110B8
(en)
*
|
2006-06-02 |
2014-04-10 |
Pfizer Products Inc. |
Circulating tumor cell assay
|
CA2657621A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Aviva Biosciences Corporation |
Methods and compositions for detecting rare cells from a biological sample
|
WO2008044311A1
(fr)
*
|
2006-10-13 |
2008-04-17 |
Olympus Corporation |
Procédé d'identification d'état anormal, analyseur, et réactif
|
US20080118402A1
(en)
*
|
2006-11-21 |
2008-05-22 |
David Brancazio |
Method and apparatus for analyte processing
|
US8202491B2
(en)
|
2006-11-21 |
2012-06-19 |
Bioscale, Inc. |
Apparatus for analyte processing
|
US20090061497A1
(en)
*
|
2007-06-29 |
2009-03-05 |
Becton, Dickinson And Company |
Methods for Extraction and Purification of Components of Biological Samples
|
EP2185289B1
(de)
|
2007-08-13 |
2015-02-25 |
Agency for Science, Technology and Research |
Mikrofluidtrennsystem
|
WO2009033056A1
(en)
*
|
2007-09-06 |
2009-03-12 |
Bioscale, Inc. |
Reusable detection surfaces and methods of using same
|
DE102007043281A1
(de)
|
2007-09-11 |
2009-05-28 |
Sebastian Dr. med. Chakrit Bhakdi |
Vorrichtung, Materialien und Verfahren zur Hochgradientenmagnetseparation biologischen Materials
|
EP2205360A2
(de)
*
|
2007-10-29 |
2010-07-14 |
Philips Intellectual Property & Standards GmbH |
Separatorsäule, separatorsystem, verfahren zur fraktionierung magnetischer partikel, verfahren zur herstellung einer separatorsäule und verwendung einer separatorsäule
|
JP5349490B2
(ja)
*
|
2007-12-05 |
2013-11-20 |
ザイオミックス インコーポレイテッド |
細胞アッセイキット及び方法
|
DK2433713T3
(en)
|
2007-12-07 |
2017-09-25 |
Miltenyi Biotec Gmbh |
CELL PROCESSING SYSTEMS AND PROCEDURES
|
CN202011883U
(zh)
*
|
2007-12-12 |
2011-10-19 |
里兰斯坦福初级大学理事会 |
用于捕获和分离目标细胞的装置
|
KR101384142B1
(ko)
*
|
2007-12-28 |
2014-04-14 |
삼성디스플레이 주식회사 |
표시기판, 이의 제조방법 및 이를 갖는 표시장치
|
US8556843B2
(en)
*
|
2008-02-02 |
2013-10-15 |
AccelDx |
Blood purification method and apparatus for the treatment of malaria
|
US20110127222A1
(en)
*
|
2008-03-19 |
2011-06-02 |
Cynvenio Biosystems, Inc. |
Trapping magnetic cell sorting system
|
US20110137018A1
(en)
*
|
2008-04-16 |
2011-06-09 |
Cynvenio Biosystems, Inc. |
Magnetic separation system with pre and post processing modules
|
EP2285493A2
(de)
|
2008-06-09 |
2011-02-23 |
QIAGEN Gaithersburg, Inc. |
Magnetische mikroplattenanordnung
|
EP2347254A2
(de)
|
2008-09-16 |
2011-07-27 |
Ibis Biosciences, Inc. |
Probenverarbeitungseinheiten, -systeme und damit verbundene verfahren
|
WO2010056337A2
(en)
|
2008-11-12 |
2010-05-20 |
Caris Mpi, Inc. |
Methods and systems of using exosomes for determining phenotypes
|
US8710836B2
(en)
*
|
2008-12-10 |
2014-04-29 |
Nanomr, Inc. |
NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
|
US8790916B2
(en)
*
|
2009-05-14 |
2014-07-29 |
Genestream, Inc. |
Microfluidic method and system for isolating particles from biological fluid
|
CN113145296B
(zh)
*
|
2009-05-15 |
2024-03-29 |
简·探针公司 |
用于在执行磁性分离工序的仪器中实现磁体的自动移动的方法和设备
|
CN102713640B
(zh)
*
|
2009-06-10 |
2015-09-16 |
辛温尼奥生物系统公司 |
鞘流装置和方法
|
CN102470373B
(zh)
*
|
2009-07-17 |
2014-11-26 |
皇家飞利浦电子股份有限公司 |
用于富集磁性粒子的设备
|
BR112012005618B1
(pt)
|
2009-10-28 |
2020-03-10 |
Magglobal, Llc |
Dispositivo de separação magnética
|
GB2476825B
(en)
*
|
2010-01-12 |
2011-12-07 |
Eclipse Magnetics Ltd |
Magnetic filtration apparatus
|
AU2011205230A1
(en)
|
2010-01-13 |
2012-08-02 |
Caris Life Sciences Switzerland Holdings Gmbh |
Detection of gastrointestinal disorders
|
CN103237901B
(zh)
|
2010-03-01 |
2016-08-03 |
卡里斯生命科学瑞士控股有限责任公司 |
用于治疗诊断的生物标志物
|
WO2011127219A1
(en)
|
2010-04-06 |
2011-10-13 |
Caris Life Sciences Luxembourg Holdings |
Circulating biomarkers for disease
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
US9428547B2
(en)
|
2010-04-21 |
2016-08-30 |
Dna Electronics, Inc. |
Compositions for isolating a target analyte from a heterogeneous sample
|
EP2683489A4
(de)
|
2011-03-11 |
2015-08-12 |
Guisheng Yang |
Vorrichtung und verfahren zur spülung von magnetteilchen
|
WO2012145658A1
(en)
|
2011-04-20 |
2012-10-26 |
Magnetation, Inc. |
Iron ore separation device
|
BR112013024148B1
(pt)
|
2011-04-27 |
2022-01-25 |
Becton, Dickinson And Company |
Dispositivo, método e sistema para separar partes marcadas magneticamente em uma amostra, método de separar partes marcadas magneticamente em uma amostra
|
TW201311907A
(zh)
|
2011-07-07 |
2013-03-16 |
Veridex Llc |
使用循環內皮細胞的基因診斷
|
FR2986617B1
(fr)
*
|
2012-02-02 |
2015-03-27 |
Horiba Abx Sas |
Dispositif et procede pour effectuer des mesures hematologiques et biochimiques a partir d'un echantillon biologique
|
IN2014DN06822A
(de)
*
|
2012-08-31 |
2015-05-22 |
Toshiba Kk |
|
US9958448B2
(en)
|
2012-10-23 |
2018-05-01 |
Caris Life Sciences Switzerland Holdings Gmbh |
Aptamers and uses thereof
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
EP2912189A4
(de)
|
2012-10-26 |
2016-10-26 |
Becton Dickinson Co |
Vorrichtungen und verfahren zur manipulation von komponenten in einer flüssigkeitsprobe
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
US9939443B2
(en)
|
2012-12-19 |
2018-04-10 |
Caris Life Sciences Switzerland Holdings Gmbh |
Compositions and methods for aptamer screening
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
US20150233932A1
(en)
*
|
2013-02-19 |
2015-08-20 |
Ching-Ping Tseng |
Methods, Systems, and Compositions for Enrichment of Rare Cells
|
US20140242603A1
(en)
*
|
2013-02-26 |
2014-08-28 |
Glenn Yaguang Deng |
Methods and apparatus for target cell magnetic enrichment, isolation and biological analysis
|
US9128017B2
(en)
*
|
2013-03-19 |
2015-09-08 |
Rarecyte, Inc. |
Device, systems and methods for analyzing a target analyte
|
BR112016004153A2
(pt)
|
2013-08-28 |
2019-09-17 |
Caris Life Sciences Switzerland Holdings Gmbh |
"método para caracterizar uma doença ou distúrbio, kit, composição, método para gerar uma biblioteca de entrada, oligonucleotídeo, pluralidade de oligonucleotídeos e método para identificar um aptâmero
|
CN105980046B
(zh)
|
2013-09-09 |
2018-04-03 |
微球实验公司 |
使用具有磁性性质的颗粒的新诊断测定
|
EP3647412A1
(de)
|
2014-04-23 |
2020-05-06 |
Juno Therapeutics, Inc. |
Verfahren zur isolierung, kultivierung und genetischen manipulation von immunen zellpopulationen zur adoptiven therapie
|
CA2954414A1
(en)
|
2014-07-15 |
2016-01-21 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
KR20170068598A
(ko)
|
2014-10-20 |
2017-06-19 |
주노 쎄러퓨티크스 인코퍼레이티드 |
입양 세포 치료에서 복용을 위한 방법 및 조성물
|
CN107109438B
(zh)
|
2014-11-05 |
2021-09-03 |
朱诺治疗学股份有限公司 |
用于转导及细胞处理的方法
|
US11266739B2
(en)
|
2014-12-03 |
2022-03-08 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
CN107428833B
(zh)
|
2015-01-16 |
2021-11-02 |
朱诺治疗学股份有限公司 |
Ror1特异性抗体和嵌合抗原受体
|
WO2016145128A1
(en)
|
2015-03-09 |
2016-09-15 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
JP6949728B2
(ja)
|
2015-05-29 |
2021-10-13 |
ジュノー セラピューティクス インコーポレイテッド |
遺伝子操作された細胞における阻害相互作用を調節するための組成物および方法
|
US10590425B2
(en)
|
2015-06-29 |
2020-03-17 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
MA42895A
(fr)
|
2015-07-15 |
2018-05-23 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
US10941176B2
(en)
|
2015-07-28 |
2021-03-09 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
ES2599056B2
(es)
|
2015-07-31 |
2017-07-07 |
Pablo ALBERTOS SÁNCHEZ |
Dispositivo para ensayar una muestra de células
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
CN108474002B
(zh)
|
2015-10-22 |
2023-05-23 |
朱诺治疗学有限公司 |
用于转导的方法、反应剂盒、反应剂和设备
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
MA44314A
(fr)
|
2015-11-05 |
2018-09-12 |
Juno Therapeutics Inc |
Récepteurs chimériques contenant des domaines induisant traf, et compositions et méthodes associées
|
WO2017079703A1
(en)
|
2015-11-05 |
2017-05-11 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
MX2018006789A
(es)
|
2015-12-03 |
2019-02-13 |
Juno Therapeutics Inc |
Receptores quimericos modificados y composiciones y metodos relacionados.
|
CA3007258A1
(en)
|
2015-12-03 |
2017-06-08 |
Mark L. Bonyhadi |
Compositions and methods for reducing immune responses against cell therapies
|
EP4012415A3
(de)
|
2015-12-04 |
2022-12-07 |
Juno Therapeutics, Inc. |
Verfahren und zusammensetzungen in zusammenhang mit zelltherapieassoziierter toxizität
|
WO2017106638A1
(en)
|
2015-12-16 |
2017-06-22 |
Gritstone Oncology, Inc. |
Neoantigen identification, manufacture, and use
|
AU2017229088B2
(en)
|
2016-03-07 |
2021-05-13 |
X-Zell Inc. |
Compositions and methods for identifying rare cells
|
WO2017161208A1
(en)
|
2016-03-16 |
2017-09-21 |
Juno Therapeutics, Inc. |
Methods for determining dosing of a therapeutic agent and related treatments
|
EP3430549A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zum adaptiven design eines behandlungsplans und ähnlicher behandlungen
|
US10731166B2
(en)
|
2016-03-18 |
2020-08-04 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
MA44486A
(fr)
|
2016-03-22 |
2019-01-30 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Procédés d'intervention précoce pour prévenir ou atténuer la toxicité
|
WO2017205686A1
(en)
|
2016-05-25 |
2017-11-30 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
WO2017210689A1
(en)
|
2016-06-03 |
2017-12-07 |
Memorial Sloan-Kettering Cancer Center |
Adoptive cell therapies as early treatment options
|
MA45341A
(fr)
|
2016-06-06 |
2019-04-10 |
Hutchinson Fred Cancer Res |
Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
|
CN110291402B
(zh)
|
2016-06-27 |
2023-09-01 |
朱诺治疗学股份有限公司 |
鉴定肽表位的方法、结合此类表位的分子和相关用途
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
CA3031955A1
(en)
|
2016-07-29 |
2018-02-01 |
Juno Therapeutics, Inc. |
Immunomodulatory polypeptides and related compositions and methods
|
AU2017301881A1
(en)
|
2016-07-29 |
2019-02-07 |
Juno Therapeutics, Inc. |
Methods for assessing the presence or absence of replication competent virus
|
US20240018268A1
(en)
|
2016-07-29 |
2024-01-18 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies against anti-cd19 antibodies
|
EP3957997A1
(de)
|
2016-08-26 |
2022-02-23 |
Juno Therapeutics, Inc. |
Verfahren zur zählung von partikeln in einer zellzusammensetzung
|
RU2755725C2
(ru)
|
2016-09-12 |
2021-09-20 |
Джуно Терапьютикс, Инк. |
Сборочные узлы перфузионных биореакторных мешков
|
US11072660B2
(en)
|
2016-10-03 |
2021-07-27 |
Juno Therapeutics, Inc. |
HPV-specific binding molecules
|
CN110381963A
(zh)
|
2016-10-13 |
2019-10-25 |
朱诺治疗学股份有限公司 |
涉及色氨酸代谢途径调节剂的免疫治疗方法和组合物
|
AU2017355544A1
(en)
|
2016-11-03 |
2019-05-16 |
Juno Therapeutics, Inc. |
Combination therapy of a T cell therapy and a BTK inhibitor
|
MA46716A
(fr)
|
2016-11-03 |
2019-09-11 |
Juno Therapeutics Inc |
Polythérapie de thérapie cellulaire et d'inhibiteur de la microglie
|
EP3548622A1
(de)
|
2016-12-02 |
2019-10-09 |
Juno Therapeutics, Inc. |
Manipulierte b-zellen sowie zugehörige zusammensetzungen und verfahren
|
EP3548046A2
(de)
|
2016-12-03 |
2019-10-09 |
Juno Therapeutics, Inc. |
Verfahren und zusammensetzungen zur verwendung von therapeutischen t-zellen in kombination mit kinaseinhibitoren
|
CN110248678A
(zh)
|
2016-12-03 |
2019-09-17 |
朱诺治疗学股份有限公司 |
调节car-t细胞的方法
|
KR20190104528A
(ko)
|
2016-12-03 |
2019-09-10 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Car-t 세포들 투여를 결정하는 방법
|
MA46998A
(fr)
|
2016-12-05 |
2019-10-09 |
Juno Therapeutics Inc |
Production de cellules modifiées pour une thérapie cellulaire adoptive
|
EP3568414A1
(de)
|
2017-01-10 |
2019-11-20 |
Juno Therapeutics, Inc. |
Epigenetische analyse einer zelltherapie und zugehörige verfahren
|
MX2019008538A
(es)
|
2017-01-20 |
2019-11-05 |
Juno Therapeutics Gmbh |
Conjugados de superficie celular y composiciones y métodos celulares relacionados.
|
WO2018151836A1
(en)
|
2017-02-17 |
2018-08-23 |
Fred Hutchinson Cancer Research Center |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
WO2018157171A2
(en)
|
2017-02-27 |
2018-08-30 |
Juno Therapeutics, Inc. |
Compositions, articles of manufacture and methods related to dosing in cell therapy
|
EP3595440A2
(de)
|
2017-03-14 |
2020-01-22 |
Juno Therapeutics, Inc. |
Verfahren zur kryogenen speicherung
|
CA3056261A1
(en)
|
2017-04-07 |
2018-10-11 |
Juno Therapeutics, Inc. |
Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods
|
AU2018251188A1
(en)
|
2017-04-14 |
2019-10-31 |
Juno Therapeutics, Inc. |
Methods for assessing cell surface glycosylation
|
SG11201909931PA
(en)
|
2017-04-27 |
2019-11-28 |
Juno Therapeutics Gmbh |
Oligomeric particle reagents and methods of use thereof
|
IL310031A
(en)
|
2017-05-01 |
2024-03-01 |
Juno Therapeutics Inc |
A combination of cellular therapy and an immune modulatory compound
|
MX2019014268A
(es)
|
2017-06-02 |
2020-08-03 |
Juno Therapeutics Inc |
Artículos de manufactura y métodos para tratamiento usando terapia celular adoptiva.
|
CA3064597A1
(en)
|
2017-06-02 |
2018-12-06 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods related to toxicity associated with cell therapy
|
US20220225597A1
(en)
|
2017-06-29 |
2022-07-21 |
Juno Therapeutics, Inc. |
Mouse model for assessing toxicities associated with immunotherapies
|
JP7337773B2
(ja)
|
2017-07-29 |
2023-09-04 |
ジュノー セラピューティクス インコーポレイテッド |
組換え受容体を発現している細胞を増大させるための試薬
|
US20200239910A1
(en)
|
2017-08-09 |
2020-07-30 |
Juno Therapeutics, Inc. |
Methods and compositions for preparing genetically engineered cells
|
US11851678B2
(en)
|
2017-08-09 |
2023-12-26 |
Juno Therapeutics, Inc. |
Methods for producing genetically engineered cell compositions and related compositions
|
MA50057A
(fr)
|
2017-09-01 |
2020-07-08 |
Juno Therapeutics Inc |
Expression génique et évaluation d'un risque de développement d'une toxicité suite à une thérapie cellulaire
|
EP3679370A1
(de)
|
2017-09-07 |
2020-07-15 |
Juno Therapeutics, Inc. |
Verfahren zur identifizierung von zellulären attributen im zusammenhang mit den ergebnissen einer zelltherapie
|
EP3692063A1
(de)
|
2017-10-03 |
2020-08-12 |
Juno Therapeutics, Inc. |
Hpv-spezifische bindungsmoleküle
|
WO2019075112A1
(en)
|
2017-10-10 |
2019-04-18 |
Gritstone Oncology, Inc. |
IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS
|
BR112020008565A2
(pt)
|
2017-11-01 |
2020-10-20 |
Juno Therapeutics Inc |
processo para a produção de uma composição de célula t
|
JP7256197B2
(ja)
|
2017-11-01 |
2023-04-11 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞成熟抗原に特異的な抗体およびキメラ抗原受容体
|
WO2019089848A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods associated with tumor burden for assessing response to a cell therapy
|
CN111542596A
(zh)
|
2017-11-01 |
2020-08-14 |
朱诺治疗学股份有限公司 |
产生工程化细胞的治疗性组合物的方法
|
MX2020004572A
(es)
|
2017-11-01 |
2020-10-07 |
Juno Therapeutics Inc |
Receptores de antigenos quimericos especificos para el antigeno de maduracion de celulas b y polinucleotidos que codifican los mismos.
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
AU2018359907A1
(en)
|
2017-11-06 |
2020-05-07 |
Fred Hutchinson Cancer Center |
Combination of a cell therapy and a gamma secretase inhibitor
|
MA50571A
(fr)
|
2017-11-10 |
2020-09-16 |
Juno Therapeutics Inc |
Réservoirs cryogéniques à système fermé
|
JP2021503897A
(ja)
|
2017-11-22 |
2021-02-15 |
グリットストーン オンコロジー インコーポレイテッド |
新生抗原のためのジャンクションエピトープ提示の低減
|
MA51210A
(fr)
|
2017-12-01 |
2020-10-07 |
Juno Therapeutics Inc |
Procédés de dosage et de modulation de cellules génétiquement modifiées
|
US20210207080A1
(en)
|
2017-12-08 |
2021-07-08 |
Juno Therapeutics, Inc. |
Serum-free media formulation for culturing cells and methods of use thereof
|
CA3084445A1
(en)
|
2017-12-08 |
2019-06-13 |
Juno Therapeutics, Inc. |
Process for producing a composition of engineered t cells
|
AU2018379094A1
(en)
|
2017-12-08 |
2020-06-25 |
Juno Therapeutics, Inc. |
Phenotypic markers for cell therapy and related methods
|
US20210070845A1
(en)
|
2017-12-15 |
2021-03-11 |
Juno Therapeutics, Inc. |
Anti-cct5 binding molecules and methods of use thereof
|
EP3746117A1
(de)
|
2018-01-31 |
2020-12-09 |
Celgene Corporation |
Kombinationstherapie unter verwendung von adoptiver zelltherapie und checkpoint-inhibitor
|
WO2019152747A1
(en)
|
2018-01-31 |
2019-08-08 |
Juno Therapeutics, Inc. |
Methods and reagents for assessing the presence or absence of replication competent virus
|
US20200393355A1
(en)
|
2018-02-28 |
2020-12-17 |
Juno Therapeutics, Inc. |
Methods for detecting particles present in a cell composition
|
US20210046159A1
(en)
|
2018-03-09 |
2021-02-18 |
Ospedale San Raffaele S.R.L. |
Il-1 antagonist and toxicity induced by cell therapy
|
SG11202009284TA
(en)
|
2018-04-05 |
2020-10-29 |
Juno Therapeutics Inc |
T cell receptors and engineered cells expressing same
|
CN112585276A
(zh)
|
2018-04-05 |
2021-03-30 |
朱诺治疗学股份有限公司 |
产生表达重组受体的细胞的方法和相关组合物
|
BR112020020073A2
(pt)
|
2018-04-05 |
2021-01-05 |
Juno Therapeutics Inc |
Células t que expressam um receptor recombinante, polinucleotídeos relacionados e métodos
|
KR20210044736A
(ko)
|
2018-05-03 |
2021-04-23 |
주노 쎄러퓨티크스 인코퍼레이티드 |
키메라 항원 수용체(car) t세포 요법과 키나제 억제제의 조합요법
|
SG11202012299SA
(en)
|
2018-06-13 |
2021-01-28 |
Akron Biotechnology Llc |
Method to prepare therapeutically active aldesleukin highly stable in liquid pharmaceutical compositions
|
US11262352B2
(en)
|
2018-07-20 |
2022-03-01 |
Cornell University |
Magnetic separation of biological entities from fluid sample
|
US11278915B1
(en)
|
2018-07-20 |
2022-03-22 |
NeoGeneStar LLC |
Device for capturing and releasing magnetic particles
|
AU2019318560A1
(en)
|
2018-08-09 |
2021-02-25 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
MX2021001519A
(es)
|
2018-08-09 |
2021-05-27 |
Juno Therapeutics Inc |
Metodos para valorar acidos nucleicos integrados.
|
EP3843778A1
(de)
|
2018-08-31 |
2021-07-07 |
Invectys Sa |
Chimäre antigenrezeptoren gegen mehrere hla-g-isoformen
|
CN113167796A
(zh)
|
2018-09-11 |
2021-07-23 |
朱诺治疗学股份有限公司 |
对工程化细胞组合物进行质谱分析的方法
|
MX2021005022A
(es)
|
2018-11-01 |
2021-09-08 |
Juno Therapeutics Inc |
Receptores de antigenos quimericos especificos para el miembro d del grupo 5 de la clase c del receptor acoplado a proteina g (gprc5d).
|
KR20210113169A
(ko)
|
2018-11-01 |
2021-09-15 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Β세포 성숙 항원에 특이적인 키메라 항원 수용체를 이용한 치료 방법
|
JP2022512913A
(ja)
|
2018-11-06 |
2022-02-07 |
ジュノー セラピューティクス インコーポレイテッド |
遺伝子操作されたt細胞を作製するための方法
|
US20220008477A1
(en)
|
2018-11-08 |
2022-01-13 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and t cell modulation
|
SG11202105084VA
(en)
|
2018-11-16 |
2021-06-29 |
Juno Therapeutics Inc |
Methods of dosing engineered t cells for the treatment of b cell malignancies
|
AU2019387497A1
(en)
|
2018-11-30 |
2021-06-24 |
Juno Therapeutics, Inc. |
Methods for treatment using adoptive cell therapy
|
BR112021010120A2
(pt)
|
2018-11-30 |
2021-08-31 |
Juno Therapeutics, Inc. |
Métodos para dosagem e tratamento de malignidades celulares em terapia celular adotiva
|
MA54863A
(fr)
|
2019-01-29 |
2021-12-08 |
Juno Therapeutics Inc |
Anticorps et récepteurs antigéniques chimériques spécifiques du récepteur orphelin-1 de type récepteur à tyrosine kinase (ror1)
|
EP3693739A1
(de)
|
2019-02-06 |
2020-08-12 |
Stefan Schreier |
Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien
|
WO2020190377A1
(en)
*
|
2019-03-15 |
2020-09-24 |
Siemens Healthcare Diagnostics Inc. |
Method and apparatus for magnetic bead manipulation
|
AU2020265741A1
(en)
|
2019-05-01 |
2021-11-25 |
Editas Medicine, Inc. |
Cells expressing a recombinant receptor from a modified TGFBR2 Locus, related polynucleotides and methods
|
CA3136742A1
(en)
|
2019-05-01 |
2020-11-05 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified cd247 locus, related polynucleotides and methods
|
MA56206A
(fr)
|
2019-06-12 |
2022-04-20 |
Juno Therapeutics Inc |
Combinaison thérapeutique d'une thérapie cytotoxique à médiation cellulaire et d'un inhibiteur d'une protéine de la famille bcl2 pro-survie
|
CN114555112A
(zh)
|
2019-08-22 |
2022-05-27 |
朱诺治疗学股份有限公司 |
T细胞疗法和zeste增强子同源物2(ezh2)抑制剂的组合疗法及相关方法
|
US20220392613A1
(en)
|
2019-08-30 |
2022-12-08 |
Juno Therapeutics, Inc. |
Machine learning methods for classifying cells
|
US11208682B2
(en)
|
2019-09-13 |
2021-12-28 |
Western Digital Technologies, Inc. |
Enhanced optical detection for nucleic acid sequencing using thermally-dependent fluorophore tags
|
CN115087868A
(zh)
|
2019-11-05 |
2022-09-20 |
朱诺治疗学股份有限公司 |
确定治疗性t细胞组合物的属性的方法
|
JP2022554353A
(ja)
|
2019-11-07 |
2022-12-28 |
ジュノー セラピューティクス インコーポレイテッド |
T細胞療法と(s)-3-[4-(4-モルホリン-4-イルメチル-ベンジルオキシ)-1-オキソ-1,3-ジヒドロ-イソインドール-2-イル]-ピペリジン-2,6-ジオンとの併用
|
US11747329B2
(en)
*
|
2019-11-22 |
2023-09-05 |
Western Digital Technologies, Inc. |
Magnetic gradient concentrator/reluctance detector for molecule detection
|
US20230028050A1
(en)
|
2019-12-06 |
2023-01-26 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to bcma-targeted binding domains and related compositions and methods
|
CN115398231A
(zh)
|
2019-12-06 |
2022-11-25 |
朱诺治疗学股份有限公司 |
与治疗b细胞恶性肿瘤的细胞疗法相关的毒性和反应的相关方法
|
JP2023504736A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
Gprc5d標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
BR112022014501A2
(pt)
|
2020-01-24 |
2022-09-20 |
Juno Therapeutics Inc |
Métodos para dosagem e tratamento de linfoma folicular e linfoma de zona marginal em terapia celular adotiva
|
US20230090117A1
(en)
|
2020-01-28 |
2023-03-23 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
KR20220152227A
(ko)
|
2020-02-12 |
2022-11-15 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Bcma-지시된 키메라 항원 수용체 t 세포 조성물 및 이의 방법 및 용도
|
AU2021220875A1
(en)
|
2020-02-12 |
2022-09-29 |
Juno Therapeutics, Inc. |
CD19-directed chimeric antigen receptor T cell compositions and methods and uses thereof
|
BR112022020333A2
(pt)
|
2020-04-10 |
2022-11-22 |
Juno Therapeutics Inc |
Métodos e usos relacionados à terapia celular projetada com um receptor de antígeno quimérico que alveja o antígeno de maturação de células b
|
CA3181399A1
(en)
|
2020-04-28 |
2021-11-04 |
Juno Therapeutics, Inc. |
Combination of bcma-directed t cell therapy and an immunomodulatory compound
|
KR20230024283A
(ko)
|
2020-05-13 |
2023-02-20 |
주노 쎄러퓨티크스 인코퍼레이티드 |
임상 반응과 관련된 특징을 식별하는 방법 및 이의 용도
|
KR20230022868A
(ko)
|
2020-05-13 |
2023-02-16 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 공여자-배치 세포의 제조 방법
|
KR20230042283A
(ko)
|
2020-06-26 |
2023-03-28 |
주노 테라퓨틱스 게엠베하 |
재조합 수용체를 조건부로 발현하는 조작된 t 세포, 관련된 폴리뉴클레오티드 및 방법
|
US20230324408A1
(en)
|
2020-08-05 |
2023-10-12 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to ror1-targeted binding domains and related compositions and methods
|
CN116802203A
(zh)
|
2020-11-04 |
2023-09-22 |
朱诺治疗学股份有限公司 |
从经修饰的恒定cd3免疫球蛋白超家族链基因座表达嵌合受体的细胞、相关多核苷酸和方法
|
WO2022133030A1
(en)
|
2020-12-16 |
2022-06-23 |
Juno Therapeutics, Inc. |
Combination therapy of a cell therapy and a bcl2 inhibitor
|
EP4301755A1
(de)
|
2021-03-03 |
2024-01-10 |
Juno Therapeutics, Inc. |
Kombination aus t-zelltherapie und dgk-hemmer
|
JP2024511418A
(ja)
|
2021-03-22 |
2024-03-13 |
ジュノー セラピューティクス インコーポレイテッド |
治療用細胞組成物の効力を決定する方法
|
EP4313126A1
(de)
|
2021-03-29 |
2024-02-07 |
Juno Therapeutics, Inc. |
Kombination aus einer car-t-zelltherapie und einer immunmodulatorischen verbindung zur behandlung von lymphomen
|
CN117858719A
(zh)
|
2021-03-29 |
2024-04-09 |
朱诺治疗学股份有限公司 |
使用检查点抑制剂疗法和car t细胞疗法的组合进行给药和治疗的方法
|
AU2022258832A1
(en)
|
2021-04-16 |
2023-10-19 |
Celgene Corporation |
Combination therapies with bcma-directed t cell therapy
|
CN113391010B
(zh)
*
|
2021-07-07 |
2023-03-24 |
安图实验仪器(郑州)有限公司 |
临床自动分析仪器的进样方法
|
DE202021105458U1
(de)
|
2021-10-08 |
2023-01-24 |
Sanolibio Co., Ltd. |
Vorrichtung zur magnetischen Aufreinigung biologischer Proben
|
WO2023081735A1
(en)
|
2021-11-03 |
2023-05-11 |
Celgene Corporation |
Chimeric antigen receptors specific for b-cell maturation antigen for use in treating myeloma
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023147515A1
(en)
|
2022-01-28 |
2023-08-03 |
Juno Therapeutics, Inc. |
Methods of manufacturing cellular compositions
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
WO2023230548A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Method for predicting response to a t cell therapy
|
WO2023250400A1
(en)
|
2022-06-22 |
2023-12-28 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
WO2024006960A1
(en)
|
2022-06-29 |
2024-01-04 |
Juno Therapeutics, Inc. |
Lipid nanoparticles for delivery of nucleic acids
|
WO2024031091A2
(en)
|
2022-08-05 |
2024-02-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for gprc5d and bcma
|
WO2024044779A2
(en)
|
2022-08-26 |
2024-02-29 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3)
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|